Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 28,971 | 110 | 34 | 35 | 36,005 |
| Gross Profit | 40 | 110 | 30 | 30 | 30 |
| Operating Expenses | 1,140 | 3,680 | 1,400 | 950 | 920 |
| Operating Income | 27,831 | -3,570 | -1,366 | -915 | 35,085 |
| Other Income | -28,941 | -90 | 96 | -5 | -35,985 |
| Pre-tax Income | -1,110 | -3,660 | -1,270 | -920 | -900 |
| Income Tax | 1 | -470 | 0 | -90 | -100 |
| Net Income Continuous | -748 | -987 | -1,262 | -821 | -802 |
| Net Income | $-748 | $-987 | $-1,262 | $-821 | $-802 |
| EPS Basic Total Ops | -0.28 | -0.38 | -0.57 | -0.38 | -0.38 |
| EPS Basic Continuous Ops | -0.32 | -0.42 | -0.57 | -0.40 | -0.40 |
| EPS Diluted Total Ops | -0.28 | -0.38 | -0.57 | -0.38 | -0.38 |
| EPS Diluted Continuous Ops | -0.32 | -0.42 | -0.57 | -0.40 | -0.40 |
| EBITDA(a) | $27,981 | $-3,090 | $-1,366 | $-905 | $35,165 |